Lilly looks to Japanese partner for TB progress
This article was originally published in Scrip
Executive Summary
The LillyTB Drug Discovery Initiative and Japan's Microbial Chemistry Research Foundation (MCRF) are looking to complete preclinical studies on a promising new compound for drug-resistant tuberculosis by 2010, and to take it into the clinic within a few years.